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Summary 
Flow cytometry is a powerful analytical technique, which is increasingly being used to study the 
interaction between host cells and intracellular pathogens. Flow cytometry is capable of measuring a 
greater number of infected cells within a sample compared to alternative techniques such as 
fluorescence microscopy. This means that robust quantification of rare events during infection is 
possible. Our lab and others have developed flow cytometry methods to study interactions between 
host cells and intracellular pathogens, such as Cryptococcus neoformans, to quantify phagocytosis, 
intracellular replication and non-O\WLF H[SXOVLRQ RU µYRPRF\WRVLV¶ IURP WKH SKDJRVRPH. Herein we 
describe these methods and how they can be applied to the study of C. neoformans as well as other 
similar intracellular pathogens. 
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Mycology 
1. Introduction 
1.1 Cryptococcus neoformans and Cryptococcus gattii 
The Cryptococcus genus is part of the basidiomycete phylum of the fungal kingdom of life. The genus 
contains over 50 described species, however almost all human and veterinary cases of cryptococcal 
infection are caused by just two species ± Cryptococcus neoformans and Cryptococcus gattii. 
Although these two species are closely related they present with different pathologies during 
infection. C. neoformans is an opportunistic pathogen of individuals with existing immune 
deficiencies whereas C. gattii can infect immune competent hosts. During infection both fungal 
species interact with host phagocytes in the lungs and phagocytosis by host alveolar macrophages 
provides an intracellular niche for Cryptococcus to replicate (4). However, occasionally cryptococci 
can escape from the macrophage via a process known as non-O\WLFH[SXOVLRQRUµYRPRF\WRVLV¶ (3, 5, 
6). The central role of macrophages during cryptococcal infection makes this host pathogen 
interaction a key area of Cryptococcus research. In vitro cell culture is often used to study this 
interaction as in many cases, the interaction between Cryptococcus species and macrophages cultured 
in vitro can be used as a reliable indicator of virulence in vivo (2, 7).  
Methods to quantify cryptococcal parasitism of macrophages with flow cytometry have been 
previously published by our lab and others (1-3).  Typically, such methods exploit Cryptococcus 
strains with a genomic fluorescent tag (1), or a combination of antibody and cell dye stains (2, 3). 
Herein we will describe our previously published method for flow cytometry analysis of cryptococcal 
phagocytosis by macrophages and subsequent Cryptococcus replication within the phagosome (1). 
1.2 Creating fluorescently tagged Cryptococcus strains 
Our protocol relies on the use of Cryptococcus strains that have been genetically modified to express 
a fluorescent marker protein such as green fluorescent protein (GFP). During the development of this 
assay we created two fluorescent strains in the H99 (C. neoformans var. grubii serotype A, genotype 
VNI) and R265 (C. gattii serotype B, genotype VGII) genetic backgrounds. These two strains are both 
FRPPRQµZLOGW\SH¶UHIHUHQFHVWUDLQV used by many Cryptococcus researchers. 
The step by step generation the H99-GFP and R265-GFP used in this study can be found in our 
previous publication (1) but, in brief, cryptococci were transformed via biolistic delivery with an 
insertion cassette containing the GFP gene flanked upstream by the Cryptococcus JEC21 actin 
promoter act1 and downstream by the JEC21 tryptophan terminator trp1.  
  
For an investigator seeking to make their own fluorescently tagged strains a number of factors must 
be considered once stable transformants have been produced to ensure valid results in the flow 
cytometry assay. It must be ensured that the insertion of the transgene and/or its expression has not 
significantly altered the physiology of the fluorescent mutant in comparison to its wild type parent. 
This process is important as it helps to ensure the validity of all future findings using the transformed 
strain (see Note 1).  
2. Materials 
2.1 Cells and strains 
1. J774.A1 cells were acquired from the European Collection of Authenticated Cell 
Cultures (ECACC). 
2. The genetic background for the fluorescent Cryptococcus neoformans mutants used 
was H99 C. neoformans var grubii. serotype A. 
2.2 Specialist equipment 
1. Class II laminar flow hood: Cryptococcus neoformans is a class II organism and as 
such should be worked on inside a class II safety hood to protect the user. 
Additionally, cells in culture are easily susceptible to outside contamination; 
therefore, any work with uninfected cells should be performed within a laminar flow 
hood. 
2. Tissue culture incubator: mammalian cells such a J774 cells should be grown in a 
specialist incubator that can control heat, humidity and CO2 levels. J774 cells are 
grown at 37 oC with 5% CO2 and 95 % relative humidity. 
3. Haemocytometer: to determine the correct concentration of Cryptococcus neoformans 
cells for infection a haemocytometer counting chamber should be used. A BS 748 
standard haemocytometer with a chamber depth of 0.1 mm is recommended. 
4. Flow cytometer ± this protocol requires a flow cytometer that is capable of exciting 
and measuring GFP (excitation wavelength 395 nm, and detection wavelength 509 
nm). 
2.3 Media (Macrophage) 
1. Serum supplemented DMEM: 'XOEHFFR¶V0RGified Eagle medium, low glucose, 10 
% v/v Fetal bovine serum (FBS), 1 % v/v 10,000 units Penicillin & 10 mg/ml 
streptomycin, 1 % v/v 200 mM L-glutamine. Keep sterile store at 4oC. 
  
2. Serum free DMEM: 'XOEHFFR¶V 0RGified Eagle medium, low glucose, 1 % v/v 
10,000 units Penicillin & 10 mg/ml streptomycin, 1 % v/v 200 mM L-glutamine. 
Keep sterile and store at 4oC. 
2.4 Media (Cryptococcus) 
x YPD (Yeast, peptone, dextrose) liquid growth media: 1 % w/v peptone, 1 % w/v 
yeast extract and 2 % w/v D-(+)-glucose. Autoclave to sterilise. 
x YPD agar: Liquid YPD growth media + 2 % w/v agar. Autoclave to sterilise, pour 
into 9 cm Petri dishes. 
2.5 Miscellaneous reagents 
x Phorbol 12-myristate 13-acetate (PMA): l mg/ml PMA in dimethyl sulfoxide 
(DMSO) store at -20 oC aliquoted. 
x Phosphate buffered saline (1x PBS): 8 g/L sodium chloride, 0.2 g/L potassium 
chloride, 1.15 g/L disodium hydrogen phosphate, 0.2 g/L potassium dihydrogen 
phosphate, in deionised H2O pH 7.3, autoclave to sterilise and store at room 
temperature. 
x 18B7 antibody (: 10 mg/ml in 100 % glycerol (a kind gift from Arturo Casadevall, 
Johns Hopkins Bloomberg School of Public Health, Maryland USA), mouse IgG 
against Cryptococcus capsule polysaccharide Glucuronoxylomannan store at -20 oC 
aliquoted. 
x Accutase: use at concentration suggested by manufacturer, store at -20oC aliquoted. 
x Fixing media: 2 % w/v formaldehyde, 2 % v/v FBS in 1x PBS, store at -20 oC 
aliquoted, once thawed discard within 2 weeks. 
 
  
  
3. Protocol 
3.1 Experimental design 
1. C. neoformans samples to be analysed by this protocol need to be fluorescently tagged. 
Additionally, a sample that contains macrophages infected with a non-fluorescent C. 
neoformans strain is also need as a control for the flow cytometer (see section 3.4). 
Ideally this non fluorescent strain should be the same genetic background as the 
fluorescent Cryptococcus strain.  
2. For each condition, 4 duplicate infections need to be prepared (e.g. four separate wells) 
for measurement at each time point. The following time points are recommended for 
the calculation of intracellular proliferation - 0 hours (2 hours post infection, 
immediately after washing away extracellular yeast), 18 hours (20 hours post 
infection), 24 hours (26 hours post infection) and 48 hours (50 hours post infection) 
(see Note 2). 
 3.2 Cryptococcus preparation 
Long term, Cryptococcus strains can be stored at ± 80 oC in glycerol stocks or using Biobank storage 
beads. For experimentation Cryptococcus strains are grown on YPD agar at 25 oC and stored at 4 oC.  
1. Prepare overnight cultures of the fluorescently tagged Cryptococcus strain from YPD 
agar stock plates 24 hours prior to the start of the assay. Grow overnight cultures in 2 
ml YPD broth with constant rotational movement to prevent sedimentation. 
2. On the day of experiment, transfer 1 ml of the overnight culture into a sterile 1.5 ml 
microcentrifuge tube and wash 3 times with sterile PBS. 
3. Once washed, count the overnight culture with a haemocytometer (a 1:20 dilution of 
the overnight is usually sufficient for accurate counting) and dilute to a concentration 
of 1x107 Cryptococcus cells per 1ml in PBS in 1.5 ml microcentrifuge tubes. 
4. Opsonise Cryptococcus IRUKRXUZLWKȝJPODQWLFDSVXODU%DQWLERG\DNLQG
gift from Arturo Casadevall, Albert Einstein College of Medicine, New York USA) 
for best results put microcentrifuge tubes on a rotator. Alternatively, C. neoformans 
can be opsonised with pooled human serum (separated from donor blood). 
3.3 Macrophage infection  
The J774 murine macrophage cell line is used here as an example, however this protocol could easily 
be adapted for other in vitro cell lines or in vitro cultured primary monocytes/macrophages. While the 
basic principles remain the same, when using this protocol for other cell types it will be important to 
adjust the media and growing conditions to best suit the cells used. 
  
1. Before experimentation maintain J774 macrophages in serum supplemented (10 % 
FBS) DMEM media for at least 4 passages (from liquid nitrogen storage) before use, 
only use J774 cells between passages 4 and 15. Maintain J774 cells in T75 tissue 
culture flasks and incubate at 37 oC with 5 % CO2 (see Note 2). 
2. 24 hours prior to the start of the experiment, take a confluent T75 flask of J774 cells 
and seed into a 24-well plate at a concentration of 1x105 cells per well in 1 ml serum 
supplemented DMEM. Incubate the plate for 24 hours at 37 oC, 5 % CO2. 
3. 1 hour before the start of the experiment, activate the seeded macrophages by 
removing the media and replacing with 1 ml serum free DMEM media supplemented 
with 150 ng/ml phorbol 12-myristate 13-acetate (PMA) per well. Incubate for 1 hour 
at 37 oC, 5 % CO2 
4. After 1 hour incubation, remove the media from each well and replace with 1 ml 
serum-free DMEM. 
5. Infect the macrophage monolayer by adding 100 ȝO washed and opsonised 
fluorescently tagged C. neoformans (1x107 Cryptococcus per ml, see step 3 in µ
Cryptococcus SUHSDUDWLRQ¶,QFXEDWHIRUKRXUVDWoC, 5 % CO2. 
6. After 2 hours incubation, aspirate the media from each well and wash gently with 
37oC PBS to remove extracellular, non phagocytosed cryptococci.  Repeat this wash 
step, checking periodically under a tissue culture microscope to check for remaining 
extracellular Cryptococcus cells (see Notes 3 and 4). 
7. Once extracellular cryptococci cells have been washed away, add 250 ȝO accutase to 
each well and incubated for 15 minutes at 37 oC.  After this incubation, gently pipette 
the accutase to disassociate infected macrophages from the growing surface and to 
create a single cell suspension. 
3.4 Flow cytometer setup 
The setup for each flow cytometer is different. This assay was developed using a FACSCaliber (BD 
Biosciences), it should be possible to perform this assay using any flow cytometer that can detect 
GFP. 
1. Take the cell suspensions from the previous step. Fix the samples by adding an equal 
volume of fixing media (2% formaldehyde, 2 % fetal bovine calf serum in PBS) to 
the accutase samples (see Note 5). 
2. To setup the flow cytometer, first calibrate the instrument using a non-fluorescent 
control ± (macrophages infected with a non fluorescent C. neoformans strain). Using 
the dot plot output adjust the forward scatter (FSC-H) and side scatter (SSC-H) 
parameters to ensure that all populations of interest are visible. Using the same non-
  
fluorescent control also adjust the GFP detection channel (in this case FL1-H) using a 
histogram output to set the negative fluorescent signal to a baseline value (on most 
instruments this is three log10 from the detection maximum).  
3. Analyse each sample, making sure to keep the same calibration settings throughout 
the experiment. To enable reliable comparison between samples, collect events for 
each sample over a fixed period. Ideally 10,000 events should be collected for each 
sample to provide reliable data. 
 
3.5 Data analysis 
1. Phagocytosis ± Display the collected data on a dot plot with FSC-+RQWKHµ;¶D[LV
and FL1-H RQWKHµ<¶D[LVDVLQILJXUH). The rate of phagocytosis can be calculated 
by comparing the number of macrophages with intracellular yeast (Figure 2 
µ5HJLRQ¶ WR WKH QXPEHU RI PDFURSKDJHV ZLWKRXt intracellular yeast (Figure 2 
µ5HJLRQ¶ 
2. Intracellular proliferation ± For each strain, collect data for a series of time points 
post infection ± 0 hours (2 hours post infection, immediately after washing away 
extracellular yeast), 18 hours (20 hours post infection), 24 hours (26 hours post 
infection) and 48 hours (50 hours post infection). Display the collected data for each 
time point on a dot plot with FSC-+RQWKHµ;¶D[LVDQG)/-H RQWKHµ<¶D[LVDVLQ
figure 2). Draw a gate around the region of the plot containing macrophages with 
intracellular yeast (Figure 2 µ5HJLRQ¶). For each time point calculate the geometric 
mean fluorescent intensity of events within this gate. To calculate the intracellular 
proliferation rate (IPR) take the time point with the highest mean fluorescent intensity 
(usually 18 hours or 24 hours) , divide this mean fluorescent intensity by the mean 
fluorescent intensity of the events at the 0 hour time point. 
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Figure 1 ± Schematic layout of pAG32_GFP plasmid used to create H99-GFP and R265-GFP (1).] 
 
Figure 2 ± Dot plot (FL1-H vs FSC-H) generated from flow cytometry data collected from a sample 
of macrophages infected with a GFP tagged Cryptococcus strain. Three cell populations have been 
µJDWHG¶± Region1 Extracellular yeast (GFP high, FSC low), Region2 Macrophages with intracellular 
yeast (GFP high, FSC high) and Region3 macrophages that do not contain intracellular yeast (GFP 
low, FSC high). 
 
 
  
4. Notes 
1. To calculate the intracellular proliferation rate, the Cryptococcus count at the maximal time 
point (e.g. the time point when Cryptococcus count is highest) is divided by the count at the 
baseline (0hr) time point. Generally, the maximal time point is either 18 hr or 24 hr. At later 
time points the fungal burden within macrophages decrease due to macrophage lysis. 
2. To confirm a newly transformed strain behaves like the original during infection, a number of 
tests should be performed. Firstly, the location of the insertion should be determined ± e.g. 
Southern blotting, genome sequencing of flanking regions. Ensure that the transformed 
fragment has not inserted into a (known) gene. Additionally check how many copies of the 
fragment have inserted into the strain (multiple insertions are possible), multiple insertions 
help to inFUHDVHDVWUDLQ¶VIOXRUHVFHQWVLJQDOKRZHYHUH[FHVVLYHH[SUHVVLRQRIWUDQVJHQHVFDQ
lead to sub-optimal growth due to increased cellular stress. Secondly the transformed strain 
should be tested in a number of culture conditions and in cell culture (preferably in the same 
cell line which will be used for the flow cytometry assay) to check for differences to the wild 
type, which again could have been caused due to insertion and/ or expression of the transgene. 
To see the full range of tests we performed on our H99-GFP and R265-GFP strains please 
refer to our previous publication (1). Finally when using the strain for flow cytometry analysis 
it must be confirmed that the fluorescent signal of the strain is resolvable from the 
background auto-fluorescence which all cells display. In the case of our strains the 
fluorescence signal was strong and easily discernible from non-transformed strains using 
spectral confocal microscopy (1). 
3. For best results never split the cells less than 1/8, while passaging as sparse cell numbers 
affects cellular viability and potentially also immunological responses.   
4. Three to four washes are usually sufficient to remove extracellular cryptococci, gentle tapping 
of the plate can be performed between washes to encourage cryptococci cells to unstuck from 
the plate surface.  
5. While washing, care must be taken to avoid washing away macrophages ± avoid pipetting 
liquid directly onto the growing surface, always pipette liquid down the edge of the well. 
6. The protocol we describe herein is a one colour assay ± needing only GFP excitation (395 
nm) and emission (509 nm) filters. The filter set used for GFP is the same used for fluorescein 
isothiocyanate (FITC) ± one of the most ubiquitous fluorophores in flow cytometry. Thus, 
almost all flow cytometers should be capable of analysing samples produced using the below 
protocol. Additional colours can be added to the protocol to allow the measurement of 
additional parameters such as phagocytosed / non phagocytosed cells or to measure 
macrophage or Cryptococcus phenotypes such as phagosomal acidification, cell viability etc. 
  
7. When preparing macrophage samples for flow cytometry, different volumes of accutase and 
fixing solution can be used to optimise sample concentration. For flow cytometry the sample 
concentration should be adjusted such that the number of events per second detected by the 
instrument is in its optimal range, this range differs between instruments. Always ensure that 
equal volumes of accutase and fixing media are used however. 
 
 
 
